BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome. (5th July 2018)
- Record Type:
- Journal Article
- Title:
- BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome. (5th July 2018)
- Main Title:
- BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome
- Authors:
- Visentin, Andrea
Imbergamo, Silvia
Scomazzon, Edoardo
Pravato, Stefano
Frezzato, Federica
Bonaldi, Laura
Pizzi, Marco
Vio, Stefania
Gregianin, Michele
Burei, Marta
Facco, Monica
Semenzato, Gianpietro
Piazza, Francesco
Trentin, Livio - Abstract:
- Is Part Of:
- British journal of haematology. Volume 185:Number 1(2019)
- Journal:
- British journal of haematology
- Issue:
- Volume 185:Number 1(2019)
- Issue Display:
- Volume 185, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 185
- Issue:
- 1
- Issue Sort Value:
- 2019-0185-0001-0000
- Page Start:
- 193
- Page End:
- 197
- Publication Date:
- 2018-07-05
- Subjects:
- richter syndrome -- ibrutinib -- idelalisib -- lenalidomide -- chronic lymphocytic leukaemia
Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15 - Journal URLs:
- http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/bjh.15440 ↗
- Languages:
- English
- ISSNs:
- 0007-1048
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 16512.xml